Project Grant HT94252310446
Award Date
8/15/23
Completion Date
8/14/26
Dollars Obligated
$778K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The Department of the Army Medical Command awarded a $711,403 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a project titled "A Noninvasive Neurotrophic Factor Treatment to Repair the Injured Spinal Cord" with a period of performance from October 1, 2024 to September 30, 2027. This project grant supports advanced biomedical research focused...
The U.S. Department of the Army Medical Command has awarded a $577,383.00 Project Grant to The Children's Hospital Corporation, doing business as Boston Children's Hospital, under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant, with a performance period from September 1, 2024 to August 31, 2027, will support the hospital's research to develop base editing techniques to improve conditioning and transplantation of bone marrow failure patients. As a...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $177,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a project to develop a nanoparticle-based CRISPR screen to identify genetic regulators of chemoresistance. The screen will be used to investigate medical solutions for the battlefield by transforming health care for service members and the public...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $796,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2021 through June 2024 to investigate the contribution of rapamycin-insensitive processes to neurological symptoms in tuberous sclerosis complex. The Military Medical Research and Development program aims to advance biomedical...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...
The federal Project Grant award in the amount of $617,367 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is being used by the Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS". The research project aims to leverage innovative gene editing techniques to enhance the...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, is providing $788,475.00 to enhance the efficacy of botulinum neurotoxin for the treatment of neurogenic bladder. The award period runs from Sep 1, 2023 to Aug 31, 2026. Boston Children's Hospital, a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical...
The Department of the Army Medical Command awarded Boston Children's Hospital a $2.788 million Project Grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2021 through June 30, 2025. The grant funds research to develop therapies for Barth Syndrome from the molecular mechanism level. Barth Syndrome is a rare genetic condition that causes cardiac abnormalities and muscle weakness. The Military Medical Research and Development program supports...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $367,969 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support the development of human inner ear organ-on-chip platforms for hearing loss drug discovery from September 1, 2021 through August 31, 2023. The organ-on-chip technology focuses on transforming healthcare for service members and the...